secwatch.observer — SEC 8-K summary
======================================

Issuer:     DarioHealth Corp. (DRIO)
CIK:        0001533998
Form:       8-K
Filed at:   2025-01-22T23:59:59+00:00
Accession:  0001104659-25-005237
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

DarioHealth closes $25.6M private placement; targets cash flow positive by end of 2025
--------------------------------------------------------------------------------

- Raised $25.6M via convertible preferred stock at conversion prices of $0.73 and $0.83; majority from existing shareholders.
- Pro forma cash balance of $40.6M as of Q3 2024; aims to achieve operational cash flow positive run rate by end of 2025.
- Preferred stock pays 10% quarterly stock dividend for first four quarters; conversion subject to stockholder approval.
- Lock-up agreements with Series B & C preferred holders to receive up to 40% additional common shares over 12 months.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1533998/000110465925005237/0001104659-25-005237-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1533998/000110465925005237/tm254039d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-005237

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer